Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie.

Schoretsanitis G, Kane JM, Correll CU, Marder SR, Citrome L, Newcomer JW, Robinson DG, Goff DC, Kelly DL, Freudenreich O, Piacentino D, Paulzen M, Conca A, Zernig G, Haen E, Baumann P, Hiemke C, Gründer G, American Society of Clinical Psychopharmacology, Pharmakopsychiatrie TTDMTFOTAFNU

Open source

DOI: 10.4088/jcp.19cs13169
Published: 2020 May 19
Container: The Journal of clinical psychiatry
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.4088/jcp.19cs13169,
  title = {Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie.},
  author = {Schoretsanitis G and Kane JM and Correll CU and Marder SR and Citrome L and Newcomer JW and Robinson DG and Goff DC and Kelly DL and Freudenreich O and Piacentino D and Paulzen M and Conca A and Zernig G and Haen E and Baumann P and Hiemke C and Gründer G and American Society of Clinical Psychopharmacology and Pharmakopsychiatrie TTDMTFOTAFNU},
  year = {2020},
  journal = {The Journal of clinical psychiatry},
  doi = {10.4088/jcp.19cs13169},
  url = {https://doi.org/10.4088/jcp.19cs13169}
}

RIS

TY  - JOUR
TI  - Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie.
AU  - Schoretsanitis G
AU  - Kane JM
AU  - Correll CU
AU  - Marder SR
AU  - Citrome L
AU  - Newcomer JW
AU  - Robinson DG
AU  - Goff DC
AU  - Kelly DL
AU  - Freudenreich O
AU  - Piacentino D
AU  - Paulzen M
AU  - Conca A
AU  - Zernig G
AU  - Haen E
AU  - Baumann P
AU  - Hiemke C
AU  - Gründer G
AU  - American Society of Clinical Psychopharmacology
AU  - Pharmakopsychiatrie TTDMTFOTAFNU
PY  - 2020
JO  - The Journal of clinical psychiatry
DO  - 10.4088/jcp.19cs13169
UR  - https://doi.org/10.4088/jcp.19cs13169
ER  -

APA

G, S., JM, K., CU, C., SR, M., L, C., JW, N., DG, R., DC, G., DL, K., O, F., D, P., M, P., A, C., G, Z., E, H., P, B., C, H., G, G., Psychopharmacology, A. S. O. C., & TTDMTFOTAFNU, P. (2020). Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie.. The Journal of clinical psychiatry. https://doi.org/10.4088/jcp.19cs13169

Source records

pubmed · retrieved 2026-09-26T22:53:40.270Z
europe-pmc · retrieved 2026-09-26T22:53:40.295Z